Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference 

Melbourne (Australia) and Indianapolis, IN (United States) | September 9, 2026

Telix advises that Dr. Christian Behrenbruch, Managing Director and Group CEO and Kevin Richardson, CEO, Precision Medicine will present at the upcoming Morgan Stanley 24th Annual Global Healthcare Conference and at the H.C. Wainwright 28th Annual Global Investment Conference, both in New York, NY.

Presentation details:

Morgan Stanley 24th Annual Global Healthcare Conference
Date: September 14, 2026
Time: 9:15 a.m. EDT (11:15 p.m. AEST)

H.C. Wainwright 28th Annual Global Investment Conference
Date: September 15, 2026
Time: 10:30 a.m. EDT (12:30 a.m. AEST, Sep 16)

Both sessions will be webcast live, and accessible through Telix’s Investor Relations website.

For more information including how to register, please visit: https://ir.telixpharma.com/events-presentations.